Centerline Biomedical, Inc. — Form D

Centerline Biomedical, Inc. of Warrensville Heights, OH, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-03. The offering totals $34.7M, of which $34.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Phil RackliffeDirectorCleveland, OH
Akhil SaklechaDirectorCleveland, OH
Vikash K GoelExecutive OfficerCleveland, OH
Vinod K GoelExecutive OfficerCleveland, OH
Phil RackliffeExecutive OfficerCleveland, OH
Michael WhitmanDirectorNewtown, PA
Todd SchwarzingerDirectorWarrensville Heights, OH
Mitch WolfDirectorWarrensville Heights, OH
Gulam KhanDirectorWarrensville Heights, OH
Gulam KhanExecutive OfficerWarrensville Heights, OH
Arnaud MarieDirectorWarrensville Heights, OH
Indrani EglestonExecutive OfficerWarrensville Heights, OH
Vinod K GoelDirectorCleveland, OH
Phil N RackliffeDirectorCleveland, OH
Phil N RackliffeExecutive OfficerCleveland, OH
Vikash N GoelExecutive OfficerCleveland, OH
Jai N GuptaDirectorCleveland, OH
Jai N GuptaExecutive OfficerCleveland, OH
Jim ZalarDirectorCleveland, OH
Jim N ZalarDirectorCleveland, OH
Karen ShanahanDirectorCleveland, OH

Other filings by this issuer (3)

FiledFormOfferingSold
2025-04-25D$15.0M$10.8M
2023-11-03D$12.7M$12.7M
2023-11-03D$13.7M$13.7M

More